Stay updated on Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The site revision identifier changed from v3.7.2 to v3.8.0. The page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-01T15:06:11.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH website terminology changes and links to transition updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T14:06:01.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.1 to v3.7.2. The page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T14:10:27.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The site footer revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T14:36:05.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, with a standard header and footer, indicating access to the study record is blocked.
    Difference
    18%
    Check dated 2026-09-20T19:44:17.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The study document revision was updated to v3.6.6 with two new update dates (2026-08-24 and 2026-08-05) and a revised file size of 1.86MB, reflecting changes to the attached document and its metadata.
    Difference
    0.2%
    Check dated 2026-08-30T22:23:10.000Z thumbnail image

Stay in the know with updates to Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial page.